HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $80
Benzinga Newsdesk 14 hours ago
Analyst RatingsNewsPrice Target
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $70 to $80.
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $70 to $80.